Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 2
2003 2
2004 3
2005 2
2006 2
2007 3
2008 5
2009 1
2010 2
2011 2
2012 3
2013 2
2014 1
2015 2
2016 1
2017 3
2018 5
2019 4
2020 8
2021 7
2022 6
2023 3
2024 3
2025 8
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.
Ascierto PA, Mandalà M, Ferrucci PF, Guidoboni M, Rutkowski P, Ferraresi V, Arance A, Guida M, Maiello E, Gogas H, Richtig E, Fierro MT, Lebbè C, Helgadottir H, Queirolo P, Spagnolo F, Tucci M, Del Vecchio M, Gonzales Cao M, Minisini AM, De Placido S, Sanmamed MF, Mallardo D, Curvietto M, Melero I, Palmieri G, Grimaldi AM, Giannarelli D, Dummer R, Chiarion Sileni V. Ascierto PA, et al. Among authors: minisini am. J Clin Oncol. 2023 Jan 10;41(2):212-221. doi: 10.1200/JCO.21.02961. Epub 2022 Sep 1. J Clin Oncol. 2023. PMID: 36049147 Clinical Trial.
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.
Ascierto PA, Mandalà M, Ferrucci PF, Guidoboni M, Rutkowski P, Ferraresi V, Arance A, Guida M, Maiello E, Gogas H, Richtig E, Quaglino P, Lebbé C, Helgadottir H, Queirolo P, Spagnolo F, Tucci M, Del Vecchio M, Gonzalez-Cao M, Minisini AM, De Placido S, Sanmamed MF, Casula M, Bulgarelli J, Pisano M, Piccinini C, Piccin L, Cossu A, Mallardo D, Paone M, Vitale MG, Melero I, Grimaldi AM, Giannarelli D, Palmieri G, Dummer R, Sileni VC. Ascierto PA, et al. Among authors: minisini am. NEJM Evid. 2024 Oct;3(10):EVIDoa2400087. doi: 10.1056/EVIDoa2400087. Epub 2024 Sep 24. NEJM Evid. 2024. PMID: 39315864 Clinical Trial.
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Ascierto PA, Casula M, Bulgarelli J, Pisano M, Piccinini C, Piccin L, Cossu A, Mandalà M, Ferrucci PF, Guidoboni M, Rutkowski P, Ferraresi V, Arance A, Guida M, Maiello E, Gogas H, Richtig E, Fierro MT, Lebbe C, Helgadottir H, Queirolo P, Spagnolo F, Tucci M, Del Vecchio M, Cao MG, Minisini AM, De Placido S, Sanmamed MF, Mallardo D, Paone M, Vitale MG, Melero I, Grimaldi AM, Giannarelli D, Dummer R, Sileni VC, Palmieri G. Ascierto PA, et al. Among authors: minisini am. Nat Commun. 2024 Jan 2;15(1):146. doi: 10.1038/s41467-023-44475-6. Nat Commun. 2024. PMID: 38167503 Free PMC article. Clinical Trial.
Antibody-drug conjugates in elderly patients with breast cancer.
Bonotto M, De Pieri G, Esposto R, Lay L, Aprile G, Puglisi F, Minisini AM. Bonotto M, et al. Among authors: minisini am. Breast. 2025 Apr;80:104428. doi: 10.1016/j.breast.2025.104428. Epub 2025 Feb 23. Breast. 2025. PMID: 40020509 Free PMC article. Review.
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review.
Garutti M, Targato G, Buriolla S, Palmero L, Minisini AM, Puglisi F. Garutti M, et al. Among authors: minisini am. Cells. 2021 May 28;10(6):1334. doi: 10.3390/cells10061334. Cells. 2021. PMID: 34071228 Free PMC article. Review.
Immunotherapy for older patients with melanoma: From darkness to light?
Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, Pascoletti G, Minisini AM. Iacono D, et al. Among authors: minisini am. Pigment Cell Melanoma Res. 2021 May;34(3):550-563. doi: 10.1111/pcmr.12917. Epub 2020 Aug 18. Pigment Cell Melanoma Res. 2021. PMID: 32745351 Review.
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics.
Foffano L, Franzoni A, Molteni E, Giudici F, Dri A, Basile D, Cucciniello L, Buriolla S, Noto C, Russo S, Nascimbeni E, Bolzonello S, Pastò B, Rossa SD, Allegri L, Bonotto M, Minisini AM, Belletti B, Damante G, Gerratana L, Puglisi F. Foffano L, et al. Among authors: minisini am. Transl Oncol. 2025 Sep;59:102456. doi: 10.1016/j.tranon.2025.102456. Epub 2025 Jun 26. Transl Oncol. 2025. PMID: 40577963 Free PMC article.
75 results